Clinical trial Recruiting at 1 site Observational Ages 19 to 48 Women only

New diagnostic tools and treatments for endometriosis

Official title: Novel Diagnostic Tools for Endometriosis and Their Exploitation for Prognosis and Prevention of Complications

Run by Turku University Hospital · NCT01301885 · Data updated 2026-11-12

This study is trying out new ways to diagnose and treat endometriosis in women to see how they can better manage the condition.

Quick facts

Study typeObservational
Ages19 Years to 48 Years
SexWomen only
Enrollment230 (estimated)
SponsorTurku University Hospital
Government
Locations4 sites (Helsinki and 3 other locations)
StatusRecruiting
StartedOctober 2005
Main results expectedDecember 2025
Study endsDecember 2028
Registry record updatedAugust 16, 2021
Trial IDNCT01301885 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include women with surgically confirmed endometriosis and those without the condition for comparison.

Probably not a fit

Patients with significant other diseases, malignancy suspicion, or those who are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on endometriosis, a chronic condition affecting many women, characterized by the presence of endometrial tissue outside the uterus. It aims to explore novel diagnostic tools and treatment options, including surgical interventions like laparoscopy and laparotomy. The study will involve women with surgically and pathologically verified endometriosis as well as a control group without the condition. The goal is to better understand the disease and improve management strategies for those affected.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic and treatment options for women suffering from endometriosis.

How similar studies have gone: Other studies have explored treatments for endometriosis, but the specific diagnostic tools and approaches in this study may offer novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* study group: surgically and pathologically verified endometriosis
* control group: existence of endometriosis ruled out in laparoscopy

Exclusion Criteria:

* no other significant disease or medication for other diseases
* suspicion of malignancy
* pregnancy
* acute infection
* insufficient understanding of Finnish language
* previous hysterectomy and/or bilateral salpingo-oophorectomy

Where it's running

  • Dept of Obstetrics and Gynecology, Turku University Central Hospital
    Turku, Finland
    Recruiting
  • Dept of Obstetrics and Gynecology, Helsinki University Hospital
    Helsinki, Finland
    Completed
  • Dept of Obstetrics and Gynecology, North Carelia Central Hospital
    Joensuu, Finland
    Completed
  • Dept of Obstetrics and Gynecology, Päijät-Häme Central Hospital
    Lahti, Finland
    Completed

Study contacts

  • Principal investigator: Antti Perheentupa, MD, PhD — Department of Obstetrics and Gynecology, Turku University Central Hospital
  • Study coordinator: Antti H Perheentupa, MD PhD
  • Email: antti.perheentupa@utu.fi
  • Phone: +358-2-3130000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.